Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lytixar in uncomplicated Gram-positive skin infection
NCT01223222Phase 2Completed
- Sponsor
- Lytix Biopharma
- Start
- Sep 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of voxvoganan, sponsored by Lytix Biopharma. Started Sep 2010; status: completed.
02
Drugs
voxvoganan
Beyond the preview
Go deeper on NCT01223222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01223222.